Save
Meet the surgeon: Biggest Achievements in Surgery – Personalized Surgical Management
ESGO eAcademy, Faculty / Presenters, 4174355
Oncogenetics in Focus: From Risk to Prevention in Women’s Cancers
ESGO eAcademy, Faculty / Presenters, 4173963
ENYGO Surgical Mentorship Webinar: Pelvic Exenteration and Reconstruction
ESGO eAcademy, Faculty / Presenters, 4169385
Recurrent Platinum-Sensitive Ovarian Cancer
ESGO eAcademy, Faculty / Presenters, 4168983
EDI Leadership webinar - Thriving as a Surgeon in a Global Career
ESGO eAcademy, Faculty / Presenters, 4168982
Beyond Survival: Psycho-Oncology, Resilience, Quality of Life and Sexuality after Cancer
ESGO eAcademy, Faculty / Presenters, 4173962
Algorithm for SLN biopsy in uterine cancers by robot-assisted laparoscopy by Jan Persson
ESGO eAcademy, Faculty / Presenters, 4159169
HPV 360° - Innovations in Vaccination and Screening
ESGO eAcademy, Faculty / Presenters, 4172646
ENYGO Surgical Mentorship Webinar: Upper Abdominal Surgery in Ovarian Cancer
ESGO eAcademy, Faculty / Presenters, 4159166
Metastatic and Recurrent Endometrial Cancer
ESGO eAcademy, Faculty / Presenters, 4152072
Flowchart Frenzy: Simplifying GTD Management
ESGO eAcademy, Faculty / Presenters, 4168911
Inspiring leaders interview with prof. Denis Querleu
ESGO eAcademy, Faculty / Presenter(s), 4174906
Meet the Surgeon: How to do fertility sparing in cervical cancer by Michael Halaska
ESGO eAcademy, Faculty / Presenters, 4151234
Inspiring leaders interview with prof. Nicole Concin
ESGO eAcademy, Faculty / Presenter(s), 4174905
Adjuvant Therapy: Whom and How to Treat?
ESGO eAcademy, Faculty / Presenters, 4152065
Tumour Board Webinar: Mechanisms of Drug Resistance: PARP, ADC, Immunotherapy
ESGO eAcademy, Faculty / Presenters, 4158222
ESGO Prevention webinar: Anal intraepithelial neoplasia
ESGO eAcademy, Faculty / Presenters, 4151572
Vulvectomy and Reconstructive Procedures after Radical Surgery
ESGO eAcademy, Faculty / Presenters, 4151393
Surgical Cornerstones in the Management of EC Patients
ESGO eAcademy, Faculty / Presenters, 4152059
Molecular Integrated Risk Group Stratification & Testing for Molecular and Conventional Parameters: When, What, Why, and How?
ESGO eAcademy, Faculty / Presenters, 4151553
DDI Cards - Hungarian version
ESGO eAcademy, Faculty / Presenter(s), 4152486
DDI Cards - Romanian version
ESGO eAcademy, Faculty / Presenter(s), 4152485
DDI Cards - Czech version
ESGO eAcademy, Faculty / Presenter(s), 4152480
DDI - Vaginal cancer
ESGO eAcademy, Faculty / Presenter(s), 4152478
DDI Cards - Hebrew version
ESGO eAcademy, Faculty / Presenter(s), 4152484
DDI Cards - Russian version
ESGO eAcademy, Faculty / Presenter(s), 4152483
DDI Cards - Finnish version
ESGO eAcademy, Faculty / Presenter(s), 4152482
DDI Cards - Spanish version
ESGO eAcademy, Faculty / Presenter(s), 4152481
Invitation to ESGO 2026 in Copenhagen
ESGO eAcademy, Mansoor Raza Mirza, 4151886
ESGO 2025 Congress Summary
ESGO eAcademy, Anna Fagotti, 4151884
Discussant at Best Oral Session - Cervical cancer
ESGO eAcademy, Maria Kyrgiou, 4151874
Comparison Of Hybrid Capture 2 Oncogenic HPV Test Performance On Evalyn- Vs Qiagen-Brush Self-Collected Specimens Among A South African Population Enriched For HIV-Positivity
ESGO eAcademy, Greta Dreyer, 4151873
Interactive Exploration of ChatGPT: 4 Case Studies
ESGO eAcademy, Christian Marth, 4151882
Interactive Exploration of ChatGPT: 4 Case Studies
ESGO eAcademy, Frederic Amant, 4151883
Discussant: Best oral session - Cervical Cancer
ESGO eAcademy, Remi Nout, 4151872
Potential Challenges for Future Surgical Trials
ESGO eAcademy, Anna Fagotti, 4151877
Patient-Reported Outcomes With Pembrolizumab Plus Chemoradiotherapy For High-Risk, Locally Advanced Cervical Cancer: Interim Analysis 2 Results From The Randomised, Double-Blind, Phase 3 ENGOT-Cx11/GOG-3047/KEYNOTE-A18 Study
ESGO eAcademy, Vladyslav Sukhin, 4151871
How to Use Natural Language Processing and ChatGPT in a Clinical Setting
ESGO eAcademy, Sander Puts, 4151881
Relevant Questions Addressed by Ongoing Surgical Trials
ESGO eAcademy, Alexandra Strojna, 4151876
A Single-Arm, Multicenter, Phase II Study On Carboplatin-Paclitaxel-Pembrolizumab In Neoadjuvant Treatment Of Locally Advanced Cervical Cancer: The MITO CERV3 Study
ESGO eAcademy, Domenica Lorusso, 4151870
Artificial Intelligence and the Future in the Surgical Theatre
ESGO eAcademy, Andrea Rosati, 4151880
Notable Surgical Trials in Gynecologic Oncology: A 10-year Overview
ESGO eAcademy, Gretchen Glaser, 4151875
Academic Randomized Phase II Trial Assessing The Inhibitor Of Programmed Cell Death Ligand 1 (PD-L1) Immune Checkpoint Atezolizumab In Combination With Chemoradiation In Locally Advanced Cervical Cancer (ATEZOLACC Trial)
ESGO eAcademy, Cyrus Chargari, 4151869
The Importance of Medical Guidelines for Non-Professionals
ESGO eAcademy, Vesna Bondžic, 4151865
A Step-By-Step Technique For VNOTES Pelvic Lymphadenectomy In Early-Stage Endometrial Cancer
ESGO eAcademy, Sanha Lee, 4151861
Care of HIV Positive Patients
ESGO eAcademy, Anisa Mburu, 4151864
Interdisciplinary Collaborations Aimed at Developing Sustainable Healthcare Technologies - The green OR
ESGO eAcademy, Frank Willem Jansen, 4151868
Use Of Indocyanine Green For Intraoperative Ureteral Identification In Difficult Hysterectomies For Gynecologic Malignancies.
ESGO eAcademy, Francesca Falcone, 4151860
Pelvic Anatomy
ESGO eAcademy, Selçuk Erkilinç, 4151859
Highlights of ESGO’s First RSG on Cervical Cancer
ESGO eAcademy, Basel Refky, 4151863
The Impact of Screening Programs on Carbon Footprint: Is Prevention the Most Effective Way?
ESGO eAcademy, Joanna Kacperczyk-Bartnik, 4151867
Vascular Reconstruction After Resection Of Vena Cava For Recurrent Endometrial Cancer
ESGO eAcademy, Michal Zikan, 4151858
Cytoreduction And Partial Cystectomy In Advanced Endometrial Cancer Performed By Robotic Assisted Surgery
ESGO eAcademy, Juan Carlos Torrejon Becerra, 4151857
RSG - A New Format Not Only for Developing Countries
ESGO eAcademy, David Cibula, 4151862
Environmental Impact of Gynaecologic Oncology Practice: How We Need to Evaluate and to Improve Our Practices
ESGO eAcademy, Thomas Gaillard, 4151866
The Role Of Hyperthermia In Intraperitoneal Chemotherapy On Abdominal Tissue Concentrations Of Cisplatin: Insights From A Porcine Model
ESGO eAcademy, Christina Harlev, 4151848
Role Of Radiomics Applied To Ultrasound In Patients With Locally Advanced Cervical Cancer: A Retrospective Multicenter Study (RU-LACC Study).
ESGO eAcademy, Camilla Culcasi, 4151847
Racial Disparities In Clinical Characteristics And Survival Of Vulvar Cancer Across Histological Subtypes: A Population-Based Cohort Study
ESGO eAcademy, Penglin Liu, 4151846
Current Aspects of the Follow-Up Care of Elderly Ppatients with Gynaecological Malignancies?
ESGO eAcademy, Maja Pakiz, 4151839
Novel Techniques: New Trials on SLN and Surgical Approach
ESGO eAcademy, Nicolò Bizzarri, 4151836
Postvoid Residual Volume Control After Radical Hysterectomy For Early Cervical Cancer
ESGO eAcademy, Naia Seminario, 4151844
Urine High Risk Human Papillomavirus Testing As An Alternative Cervical Screening Strategy: The ACES Studies
ESGO eAcademy, Jennifer Davies, 4151843
Perioperative Management of Elderly Patients
ESGO eAcademy, Jalid Sehouli, 4151838
Surgical Approach for Staging in Early-stage Ovarian Cancer and Surgical Steps for Para-aortic Lymphadenectomy
ESGO eAcademy, Ane Gerda Eriksson, 4151835
The Silva Pattern-Based Classification And Oncological Outcomes In Women Undergoing Fertility-Sparing Surgery For Early-Stage Cervical Cancer
ESGO eAcademy, Kristine Hagen, 4151842
STOMa-LeAk Ratio In Advanced Ovarian Cancer Surgery: Results Of A Restrictive Policy On The Use Of Protective Stomas
ESGO eAcademy, Virginia Vargiu, 4151841
Molecular Predictors Of Chemo-Radioresistance And Their Changes During Chemoradiation With And Without Modulated Electrohyperthermia (Oncothermia) In Patients With Locally Advanced Cervical Cancer IIb-IVa FIGO.
ESGO eAcademy, Sapiiat Isaeva, 4151840
How Do We Describe Elderly and Frailty in Our Trials?
ESGO eAcademy, Lara Maria Stričak, 4151837
Indications for Staging/Re-staging in Early-stage Ovarian Cancer
ESGO eAcademy, Martina Angeles, 4151834
Conclusion
ESGO eAcademy, Nicoletta Colombo, 4151833
Data to Decision: Navigating Treatment Options and Strategy to Optimise Treatment Outcome for Patients with Newly Diagnosed Advanced Ovarian Cancer
ESGO eAcademy, Nicoletta Colombo, 4151830
Overview of the Latest Long-Term Survival Data from First-Line PARPi Trials
ESGO eAcademy, Isabelle Ray-Coquard, 4151829
Welcome and Introduction
ESGO eAcademy, Nicoletta Colombo, 4151828
Discussant - SUROVA Study Global Real-World Treatment Strategies And Mortality Risk PredictionIn Advanced Ovarian Cancer
ESGO eAcademy, Dennis Chi, 4151818
Spatial Integration of Medical Imaging and Computational Pathology for Tumour Heterogeneity Mapping in Ovarian Cancer
ESGO eAcademy, Konstantinos Zormpas-Petridis, 4151821
Which Agents Are on the Horizon? Addressing Homologous Recombination Proficiency in Ovarian Cancer
ESGO eAcademy, Ilaria Colombo, 4151813
SUROVA Study: Global Real-World Treatment Strategies And Mortality Risk Prediction In Advanced Ovarian Cancer
ESGO eAcademy, Luis Chiva, 4151817
Discussant - Late Breaking Ovarian Cancer
ESGO eAcademy, Christian Marth, 4151816
Molecular Mechanisms of Primary and Acquired PARP Inhibitor Resistance
ESGO eAcademy, Iain McNeish, 4151812
Innovations in AI and Gynaecologic Oncology Surgery
ESGO eAcademy, Houssein EL HAJJ, 4151820
Randomized Phase II/III Trial Of 3 Vs 6 Courses Of Neoadjuvant Carboplatin-Paclitaxel Chemotherapy In Stage IIIC Or IV Epithelial Ovarian, Fallopian Tube Or Primary Peritoneal Carcinoma
ESGO eAcademy, Claudio Zamagni, 4151815
Implementation of AI-Driven Support for Ovarian Cancer Ultrasound Diagnostics
ESGO eAcademy, Elisabeth Epstein, 4151819
Chemotherapy With Or Without Pembrolizumab Followed By Maintenance With Olaparib Or Placebo For First-Line Treatment Of Advanced BRCA Non-Mutated Epithelial Ovarian Cancer: Results From The Randomized Phase 3 ENGOT-OV43/GOG-3036/KEYLYNK-001 Study
ESGO eAcademy, Ignace Vergote, 4151814
Interactive Discussion: Optimizing Advanced & Recurrent Endometrial Cancer Management
ESGO eAcademy, Shannon Westin, 4151803
Understanding the Complexity of Advanced & Recurrent Endometrial Cancer Disease and Treatment Landscape
ESGO eAcademy, Shannon Westin, 4151798
Welcome and Introduction
ESGO eAcademy, Ramez Eskander, 4151797
Sexual Dysfunction And Body Image In BRCA Mutation Carriers Before And After Prophylactic Salpingo - Oophorectomy: A Cross-Sectional Study
ESGO eAcademy, Elisa Farsi, 4151795
Genomics of STIC Lesions and Risk of Subsequent High Grade Serous Carcinoma
ESGO eAcademy, Iain McNeish, 4151789
Efficacy And Safety Of Intravenous Administration Of High-Dose Selenium For Preventing Chemotherapy-Induced Peripheral Neuropathy In Platinum-Sensitive Recurrent Ovarian, Fallopian Or Primary Peritoneal Cancer: Study Protocol For A Phase III, Double-Blind, Randomized Study
ESGO eAcademy, Ga Won Yim, 4151794
Safety Of Topical Estrogen Therapy During Adjuvant Endocrine Treatment Among Patients With Breast Cancer: A Meta-Analysis Based Expert Panel Discussion
ESGO eAcademy, Stavroula Kastora, 4151793
PRO Radical Hysterectomy
ESGO eAcademy, David Cibula, 4151786
Pathology of STIC Lesions
ESGO eAcademy, Sigurd Lax, 4151788
Radiomics-Based Ultrasound Model For Differentiating Uterine Sarcomas From Leiomyomas: The ROMUS Study In The MITO Group
ESGO eAcademy, Alessandra Rizzi, 4151792
Surgical Management of STIC – Strategies for Risk-reducing Surgery
ESGO eAcademy, Claudia Marchetti, 4151787
PRO Total Mesometrial Resection
ESGO eAcademy, Henrik Falconer, 4151785
Efficacy Of A Multi-Ingredient Coriolus Versicolor-Based Vaginal Gel On High-Risk HPV Clearance: Final Results From The PALOMA 2 Clinical Trial.
ESGO eAcademy, Damián Dexeus Carter, 4151790
Efficacy Of Transvaginal Ultrasound To Visualize The Colorectal Anastomosis And Its Integrity In An Ovarian Cancer Patients Undergoing Cytoreductive Surgery With Recto-Sigmoid Resection.
ESGO eAcademy, Chiara Caricato, 4151770
Protecting Vaginal Health: Practical Strategies after Gynaecological Cancer Treatment
ESGO eAcademy, Richárd Gábor Tóth, 4151777
Complete Pelvic Peritonectomy With Extraperitoneal Hysterectomy With Or Without En-Bloc Rectal Resection
ESGO eAcademy, Lana Bijelic, 4151769
3D-Reconstruction and Laparoscopic Liver Resection for Recurrent Ovarian Cancer: Quaternary Cytoreductive Surgery
ESGO eAcademy, Valerio Gallotta, 4151768

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.



{$cookies-google-tag-manager-description}


Save Settings